Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2 - Impact on function

Critical Reviews in Eukaryotic Gene Expression

Volumn 19, Issue 2, 2009, Pages 125-137

  Floros, Joanna ^a,b   Wang, Guirong ^a   Mikerov, Anatoly N ^a  

^a Department of Pediatrics ^*  (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Genetic variants; Innate immunity; Phagocytosis; Post translational modifications; Structure function correlations

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN A1; SURFACTANT PROTEIN A2; UNCLASSIFIED DRUG;

CRYSTAL STRUCTURE; GENE LOCUS; GENETIC VARIABILITY; HUMAN; INNATE IMMUNITY; LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION INITIATION SITE;

EID: 65949105477     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v19.i2.30     Document Type: Review

References (74)

1. Floros J, Phelps DS. Pulmonary surfactant. In: Biebuck J, Lynch C III, Maze M, Saidman LJ, Yaksh TL, Zapol WM, editors. Anesthesia: biologic foundations. Philadelphia: Lippincott-Raven; 1997. p. 1259-79.
2. Hawgood S, Poulain FR. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol. 2001;63:495-519.
3. Clark JC, Weaver TE, Iwamoto HS, Ikegami M, Jobe AH, Hull WM, Whitsett JA. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol. 1997;16(1):46-52.
4. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A. 1995;92(17):7794-8.
5. Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, Ross GF, Ikegami M, Whitsett JA. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci U S A. 2001;98(11):6366-71.
6. Floros J, Phelps DS. Pulmonary surfactant protein A; structure, expression, and its role in innate host defense. In: Nakos G, editor. Surfactant-update of intensive care medicine. Greece: University of Ioannina; 2002. p. 87-102.
7. Kishore U, Greenhough TJ, Waters P, Shrive AK,Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SPD: structure, function and receptors. Mol Immunol. 2006;43(9):1293-315.
8. Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc. 2007;4(3):252-7.
9. Sano H, Kuroki Y. The lung collectins, SP-A and SPD, modulate pulmonary innate immunity. Mol Immunol. 2005;42(3):279-87.
10. van de Wetering JK, van Golde LM, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem. 2004;271(7):1229-49.
11. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5(1):58-68.
12. Kuroki Y, Akino T. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J Biol Chem. 1991;266(5):3068-73.
13. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med. 2001;20(4):269-92.
14. Condon JC, Jeyasuria P, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A. 2004;101(14):4978-83.
15. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol. 2001;63:521-54.
16. Lawson PR, Reid KB. The roles of surfactant proteins A and D in innate immunity. Immunol Rev. 2000;173:66-78.
17. Kingma PS, Whitsett JA. In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol. 2006;6(3):277-83.
18. Griese M, Essl R, Schmidt R, Rietschel E, Ratjen F, Ballmann M, Paul K. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. Am J Respir Crit Care Med. 2004;170(9):1000-5.
19. Takahashi H, Sano H, Chiba H, Kuroki Y. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases. Curr Pharm Des. 2006;12(5):589-98.
20. Floros J, Wang G, Lin Z. Genetic diversity of human SP-A, a molecule with innate host defence and surfactant-related functions; characteristics, primary function, and significance. Curr Pharmacogenomics. 2005;3:87-95.
21. Hoover RR, Floros J. Organization of the human SPA and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol. 1998;18(3):353-62.
22. Bruns G, Stroh H, Veldman GM, Latt SA, Floros J. The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10. Hum Genet. 1987;76(1):58-62.
23. Hughes AL. Evolution of the lung surfactant proteins in birds and mammals. Immunogenetics. 2007;59(7):565-72.
24. Kolble K, Lu J, Mole SE, Kaluz S, Reid KB. Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster. Genomics. 1993;17(2):294-8.
25. Floros J, DiAngelo S, Koptides M, Karinch AM, Rogan PK, Nielsen H, Spragg RG, Watterberg K, Deiter G. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol. 1996;15(4):489-98.
26. Liu W, Bentley CM, Floros J. Study of human SPA, SP-B and SP-D loci: allele frequencies, linkage disequilibrium and heterozygosity in different races and ethnic groups. BMC Genet. 2003;4(1):13.
27. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers. 1999;15(4):269-81.
28. Karinch AM, Floros J. 5' splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol. 1995;12(1):77-88.
29. Rishi A, Hatzis D, McAlmon K, Floros J. An allelic variant of the 6A gene for human surfactant protein A. Am J Physiol Lung Cell Mol Physiol. 1992;262(5 Pt1):L566-73.
30. Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta. 1998;1408(2-3):312-22.
31. Krizkova L, Sakthivel R, Olowe SA, Rogan PK, Floros J. Human SP-A: genotype and single-strand conformation polymorphism analysis. Am J Physiol Lung Cell Mol Physiol. 1994;266(5 Pt 1):L519-27.
32. Wang G, Guo X, Floros J. Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol. 2003;284(5):L738-48.
33. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol. 2005;289(3):L497-508.
34. McCormick SM, Boggaram V, Mendelson CR. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol. 1994;266(4 Pt 1):L354-66.
35. Possmayer F. A proposed nomenclature for pulmonary surfactant-associated proteins. Am Rev Respir Dis. 1988;138(4):990-8.36. Passero MA, Tye RW, Kilburn KH, Lynn WS. Isolation and characterization of two glycoproteins from patients with alveolar proteinosis. Proc Natl Acad Sci U S A. 1973;70(4):973-6.
36. hattacharyya SN, Sahu S, Lynn WS. Structural studies on a glycoprotein isolated from alveoli of patients with alveolar proteinosis. Biochim Biophys Acta. 1976;427(1):91-106.
37. King RJ, Ruch J, Gikas EG, Platzker AC, Creasy RK. Appearance of apoproteins of pulmonary surfactant in human amniotic fluid. J Appl Physiol. 1975;39(5):735-41.
38. Metcalfe IL, Enhorning G, Possmayer F. Pulmonary surfactant-associated proteins: their role in the expression of surface activity. J Appl Physiol. 1980;49(1):34-41.
39. Whitsett JA, Ross G, Weaver T, Rice W, Dion C, Hull W. Glycosylation and secretion of surfactantassociated glycoprotein A. J Biol Chem. 1985;260(28):15273-9.
40. Lynn WS. Alveolyn-structure and source: a review. Exp Lung Res. 1984;6(3-4):191-6.
41. Floros J, Steinbrink R, Jacobs K, Phelps D, Kriz R, Recny M, Sultzman L, Jones S, Taeusch HW, Frank HA, Fritsch EF. Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J Biol Chem. 1986;261(19):9029-33.
42. Floros J, Phelps DS, Kourembanas S, Taeusch HW. Primary translation products, biosynthesis, and tissue specificity of the major surfactant protein in rat. J Biol Chem. 1986;261(2):828-31.
43. Voss T, Melchers K, Scheirle G, Schafer KP. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol. 1991;4(1):88-94.
44. Wang G, Phelps DS, Umstead TM, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L946-54.
45. Huang W, Wang G, Phelps DS, Al-Mondhiry H, Floros J. Human SP-A genetic variants and bleomycininduced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation. Am J Physiol Lung Cell Mol Physiol. 2004;286(3):L546-53.
46. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2005;288(1):L150-8.
47. Wang G, Taneva S, Keough KM, Floros J. Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B. Biochim Biophys Acta. 2007;1768(9):2060-9.
48. Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SPA2 variants, and the impact of ozone-induced oxidation. Biochemistry. 2004;43(14):4227-39.
49. Mikerov AN, White M, Hartshorn K, Wang G, Floros J. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol. 2008;197(1):9-12.
50. Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G, Phelps DS, Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol. 2008;294(1):L121-30.
51. Garcia-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry. 2002;41(47):14041-53.
52. Wang G, Guo X, DiAngelo S, Floros J. Characterization of humanized transgenic hSP-A mice: formation of tubular myelin in vivo requires both human SP-A1 and SP-A2 gene products. Am J Respir Crit Care Med. 2008;177:A318.
53. Floros J, Wang G. A point of view: quantitative and qualitative imbalance in disease pathogenesis; pulmonary surfactant protein A genetic variants as a model. Comp Biochem Physiol A Mol Integr Physiol. 2001;129(1):295-303.
54. Wang G, Myers C, Mikerov A, Floros J. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants. Biochemistry. 2007;46(28):8425-35.
55. Sanchez-Barbero F, Strassner J, Garcia-Canero R, Steinhilber W, Casals C. Role of the degree of oligomerization in the structure and function of human surfactant protein A. J Biol Chem. 2005;280(9):7659-70.
56. Head JF, Mealy TR, McCormack FX, Seaton BA. Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem. 2003;278(44):43254-60.
57. McCormick SM, Mendelson CR. Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids. Am J Physiol Lung Cell Mol Physiol. 1994;266(4 Pt 1):L367-74.
58. Hoover RR, Floros J. SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol Lung Cell Mol Physiol. 1999;276(6Pt 1):L917-24.
59. Karinch AM, Deiter G, Ballard PL, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta. 1998;1398(2):192-202.
60. Kumar AR, Snyder JM. Differential regulation of SP-A1and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol. 1998;274(2 Pt 1):L177-85.
61. Scavo LM, Ertsey R, Gao BQ. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors. Am J Physiol Lung Cell Mol Physiol. 1998;275(4 Pt 1):L653-69.
62. Takahashi H, Honda Y, Kuroki Y, Imai K, Abe S. Pulmonary surfactant protein A: a serum marker of pulmonary fibrosis in patients with collagen vascular diseases [letter]. Clin Chim Acta. 1995;239(2):213-5.
63. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest. 1996;109(4):1006-9.
64. Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol. 1999;20(1):90-8.
65. Doyle IR, Jones ME, Barr HA, Orgeig S, Crockett AJ, McDonald CF, Nicholas TE. Composition of human pulmonary surfactant varies with exercise and level of fitness. Am J Respir Crit Care Med. 1994;149(6):1619-27.
66. Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, Hess JC, Thomassen MJ, Kavuru MS, Phelps DS, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1052-63.
67. Oberley RE, George CL, Snyder JM. A new tool to investigate differences between human SP-A1 and SP-A2. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1050-1.
68. Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun. 2007;75(3):1403-12.
69. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect. 2002;110(1):79-84.
70. Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo S, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS, Floros J. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet. 2003;113:542-50.
71. Sanchez-Barbero F, Rivas G, Steinhilber W, Casals C. Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization. Biochem J. 2007;406(3):479-89.
72. Oberley RE, Snyder JM. Recombinant human SPA1 and SP-A2 proteins have different carbohydratebinding characteristics. Am J Physiol Lung Cell Mol Physiol. 2003;284(5):L871-81.
73. Hattori A, Kuroki Y, Katoh T, Takahashi H, Shen HQ, Suzuki Y, Akino T. Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids. Am J Respir Cell Mol Biol. 1996;14(6):608-19.
74. Williams MC, Hawgood S, Hamilton RL. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol. 1991;5(1):41-50.